Nifty
:
24894.25
Sensex
:
81207.17
57.95 (0.23%)
223.86 (0.28%)
Nifty
Sensex
:
:
24894.25
81207.17
57.95 (0.23%)
223.86 (0.28%)

Mukka Proteins Ltd.

Animal Feed

Rating :
41/99

BSE: 544135 | NSE: MUKKA

NSE BSE
27.30
03-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  27.25
  •  27.65
  •  26.6
  •  26.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  339278
  •  9219447.65
  •  47.39
  •  24.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 818.40
  • 18.84
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,226.40
  • N/A
  • 1.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.33%
  • 0.26%
  • 21.55%
  • FII
  • DII
  • Others
  • 2.08%
  • 0.00%
  • 2.78%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 10.76
  • -5.09

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 34.10
  • 1.95

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 38.92
  • 1.78

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
170.77
172.50
-1.00%
381.57
256.70
48.64%
303.15
516.99
-41.36%
149.19
331.87
-55.05%
Expenses
156.22
158.37
-1.36%
352.39
224.51
56.96%
261.80
498.11
-47.44%
139.63
293.86
-52.48%
EBITDA
14.56
14.13
3.04%
29.18
32.19
-9.35%
41.35
18.88
119.01%
9.57
38.01
-74.82%
EBIDTM
8.52%
8.19%
7.65%
12.54%
13.64%
3.65%
6.41%
11.45%
Other Income
2.56
2.85
-10.18%
4.15
3.27
26.91%
5.80
6.18
-6.15%
3.14
4.33
-27.48%
Interest
11.04
8.13
35.79%
10.32
6.63
55.66%
10.91
6.15
77.40%
8.72
6.35
37.32%
Depreciation
3.26
3.12
4.49%
2.82
3.34
-15.57%
3.80
3.18
19.50%
3.76
2.96
27.03%
PBT
2.81
5.73
-50.96%
20.19
25.50
-20.82%
32.45
15.73
106.29%
0.23
33.04
-99.30%
Tax
0.77
0.28
175.00%
6.10
-2.20
-
6.17
5.40
14.26%
-0.42
6.29
-
PAT
2.04
5.45
-62.57%
14.09
27.70
-49.13%
26.28
10.33
154.40%
0.65
26.75
-97.57%
PATM
1.19%
3.16%
3.69%
10.79%
8.67%
2.00%
0.43%
8.06%
EPS
0.05
0.14
-64.29%
0.45
0.91
-50.55%
0.88
0.48
83.33%
0.07
1.28
-94.53%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
1,004.68
1,006.42
1,379.83
1,177.12
770.50
603.83
Net Sales Growth
-21.39%
-27.06%
17.22%
52.77%
27.60%
 
Cost Of Goods Sold
774.37
774.66
1,135.52
941.33
634.72
513.75
Gross Profit
230.31
231.75
244.31
235.79
135.78
90.09
GP Margin
22.92%
23.03%
17.71%
20.03%
17.62%
14.92%
Total Expenditure
910.04
911.53
1,274.36
1,090.95
723.72
581.95
Power & Fuel Cost
-
5.29
7.39
8.07
4.58
3.64
% Of Sales
-
0.53%
0.54%
0.69%
0.59%
0.60%
Employee Cost
-
32.30
29.33
24.66
19.36
14.97
% Of Sales
-
3.21%
2.13%
2.09%
2.51%
2.48%
Manufacturing Exp.
-
20.99
27.89
37.65
19.14
6.81
% Of Sales
-
2.09%
2.02%
3.20%
2.48%
1.13%
General & Admin Exp.
-
9.63
6.71
4.57
4.81
4.68
% Of Sales
-
0.96%
0.49%
0.39%
0.62%
0.78%
Selling & Distn. Exp.
-
64.73
64.36
61.02
35.82
30.70
% Of Sales
-
6.43%
4.66%
5.18%
4.65%
5.08%
Miscellaneous Exp.
-
3.92
3.16
13.65
5.31
7.42
% Of Sales
-
0.39%
0.23%
1.16%
0.69%
1.23%
EBITDA
94.66
94.89
105.47
86.17
46.78
21.88
EBITDA Margin
9.42%
9.43%
7.64%
7.32%
6.07%
3.62%
Other Income
15.65
15.12
17.17
6.68
7.46
9.94
Interest
40.99
37.25
25.95
16.48
9.68
8.02
Depreciation
13.64
13.55
12.34
11.89
8.58
8.34
PBT
55.68
59.20
84.35
64.48
35.98
15.46
Tax
12.62
12.17
13.15
18.42
10.16
4.45
Tax Rate
22.67%
20.56%
15.59%
28.57%
28.24%
28.78%
PAT
43.06
46.46
70.06
44.07
24.21
8.98
PAT before Minority Interest
42.65
48.10
74.31
47.52
25.82
11.01
Minority Interest
-0.41
-1.64
-4.25
-3.45
-1.61
-2.03
PAT Margin
4.29%
4.62%
5.08%
3.74%
3.14%
1.49%
PAT Growth
-38.69%
-33.69%
58.97%
82.03%
169.60%
 
EPS
1.44
1.55
2.34
1.47
0.81
0.30

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
440.70
396.09
147.80
98.37
66.52
Share Capital
30.00
30.00
22.00
22.00
5.50
Total Reserves
410.70
366.09
125.80
76.37
61.02
Non-Current Liabilities
9.41
11.56
16.52
15.30
12.64
Secured Loans
2.35
6.22
5.36
6.88
6.12
Unsecured Loans
0.18
0.18
0.00
2.49
2.85
Long Term Provisions
2.55
1.94
1.47
1.12
0.40
Current Liabilities
610.41
520.93
402.80
273.92
272.23
Trade Payables
141.80
136.21
130.81
97.55
100.06
Other Current Liabilities
13.02
29.97
9.51
9.95
22.48
Short Term Borrowings
442.94
351.56
247.32
158.46
146.08
Short Term Provisions
12.64
3.19
15.16
7.97
3.61
Total Liabilities
1,076.32
940.80
575.16
392.30
354.79
Net Block
92.68
83.59
83.43
81.27
77.58
Gross Block
165.60
142.63
130.56
117.34
104.77
Accumulated Depreciation
72.92
59.05
47.13
36.07
27.18
Non Current Assets
150.60
124.27
111.12
105.91
97.42
Capital Work in Progress
8.56
0.00
0.00
0.00
4.03
Non Current Investment
36.66
31.10
21.34
20.53
11.75
Long Term Loans & Adv.
11.32
8.11
4.78
2.71
2.63
Other Non Current Assets
0.12
0.18
0.23
0.02
0.00
Current Assets
925.72
816.52
464.04
286.38
257.38
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
564.25
423.25
229.77
164.86
149.87
Sundry Debtors
199.82
185.34
113.27
61.33
47.89
Cash & Bank
42.28
126.81
29.02
13.89
4.19
Other Current Assets
119.37
12.41
19.38
11.60
55.44
Short Term Loans & Adv.
101.18
68.72
72.61
34.70
44.15
Net Current Assets
315.32
295.60
61.24
12.46
-14.85
Total Assets
1,076.32
940.79
575.16
392.29
354.80

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-111.93
-150.41
-56.33
4.87
1.79
PBT
60.27
87.46
65.94
35.98
15.46
Adjustment
33.48
21.84
16.94
11.12
9.56
Changes in Working Capital
-202.38
-233.68
-128.08
-36.54
-18.64
Cash after chg. in Working capital
-108.64
-124.38
-45.20
10.56
6.38
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.29
-26.03
-11.13
-5.69
-4.59
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-34.99
-47.59
-3.32
-11.48
-13.61
Net Fixed Assets
-9.02
-12.76
-5.69
-4.35
Net Investments
-9.42
-10.75
-2.96
-9.14
Others
-16.55
-24.08
5.33
2.01
Cash from Financing Activity
55.55
265.89
74.67
14.99
13.48
Net Cash Inflow / Outflow
-91.36
67.89
15.01
8.38
1.66
Opening Cash & Equivalents
94.44
26.55
11.54
3.15
1.49
Closing Cash & Equivalent
3.08
94.44
26.55
11.54
3.15

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
14.69
13.20
6.72
4.47
3.02
ROA
4.77%
9.80%
9.82%
6.91%
3.40%
ROE
11.50%
27.32%
38.61%
31.32%
17.89%
ROCE
11.82%
19.54%
24.44%
18.35%
11.08%
Fixed Asset Turnover
6.66
10.30
9.77
6.94
6.02
Receivable days
68.51
38.72
26.30
25.87
25.05
Inventory Days
175.65
84.67
59.45
74.55
80.08
Payable days
65.49
42.92
44.27
56.82
64.49
Cash Conversion Cycle
178.67
80.48
41.48
43.60
40.64
Total Debt/Equity
1.02
0.91
1.72
1.76
2.39
Interest Cover
2.62
4.37
5.00
4.72
2.93

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022

News Update:


  • Mukka Proteins completes acquisition of 51% stake in FABBCO
    2nd Sep 2025, 12:17 PM

    Pursuant to acquisition of shares, FABBCO Bio Cycle and Bio Protein Technology has become a subsidiary of the Company

    Read More
  • Mukka Proteins empanelled as Authorised Waste Processor by BSWML
    14th Aug 2025, 15:58 PM

    This milestone underscores the company’s commitment to sustainable practices, environmental responsibility, and innovation in waste processing

    Read More
  • Mukka Proteins - Quarterly Results
    13th Aug 2025, 18:51 PM

    Read More
  • Mukka Proteins gets nod to acquire 51% stake in Mukka Frozen Impex
    28th Jul 2025, 11:43 AM

    The Board of Directors of the Company at their meeting held on July 26, 2025, have approved the same

    Read More
  • Mukka Proteins gets nod to acquire 70% paid-up share capital in Mukka Proteins Vietnam
    28th Jul 2025, 10:30 AM

    The proposed investment is being made as a part of Company’s strategic investment plans to expand the core business of the Company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.